In colorectal cancer, ST3GAL6-AS1 exerts a tumor-restraining activity by recruiting histone methyltransferase MLL1 to the ST3GAL6 promoter, resulting in increased ST3GAL6 transcription and α2,3-sialylation and PI3K/AKT inhibition [102]. This evidence concerns the gene AKT1 and neoplasm.